Suchergebnisse - "Pinato, David J"

PubPharm (19)

1

Diabetes and Immune Checkpoint Inhibitors-Response

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Cortellini, A. | D'Alessio, A. | Pinato, D.

CommentOn: Clin Cancer Res. 2023 Jul 14;29(14):2714-2724. - PMID 37125965

2

The price and value of therapeutic synergy in liver cancer

enthalten in: Lancet (London, England) | 2023

von Pinato, D. | D'Alessio, A. | Celsa, C. | +2

CommentOn: Lancet. 2023 Sep 30;402(10408):1133-1146. - PMID 37499670

3

Tumor-infiltrating Neutrophils : Gatekeepers in Liver Cancer Immune Control

enthalten in: Gastroenterology | 2023

von Scheiner, B. | Pinato, D.

CommentOn: Nature. 2022 Dec;612(7938):141-147. - PMID 36352227

4

Antibiotic Therapy : The Cornerstone of Iatrogenic Resistance to Immune Checkpoint Inhibitors

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Pinato, D. | Cortellini, A.

CommentOn: J Clin Oncol. 2023 Jun 10;41(17):3122-3134. - PMID 36827626

5

Local and systemic therapy in liver cancer : the quest for synergy

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Pinter, M. | Pinato, D.

CommentOn: Lancet Gastroenterol Hepatol. 2023 Feb;8(2):169-178. - PMID 36529152

6

Dissecting the Tumor Microenvironment to Predict Immunotherapy Response in Hepatocellular Cancer

enthalten in: Gastroenterology | 2022

von D'Alessio, A. | Pinato, D.

CommentOn: Nat Med. 2022 Aug;28(8):1599-1611. - PMID 35739268

7

COSMIC-312 : mounting immunotherapy enigmas for hepatocellular carcinoma

enthalten in: The Lancet. Oncology | 2022

von Cabibbo, G. | Celsa, C. | D'Alessio, A. | +2

CommentOn: Lancet Oncol. 2022 Aug;23(8):995-1008. - PMID 35798016

8

Ketogenic Diet as a Chemopreventative and Therapeutic Strategy for Colon Cancer

enthalten in: Gastroenterology | 2022

von Pinato, D.

CommentOn: Nature. 2022 May;605(7908):160-165. - PMID 35477756

9

Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC : The Backbone Matters

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Cortellini, A. | Facchinetti, F. | Derosa, L. | +1

CommentOn: J Thorac Oncol. 2022 Jun;17(6):758-767. - PMID 35183773

10

Response to letter entitled : Re: Predictive ability of a drug-based score in advanced non-small cell lung cancer patients receiving first-line immunotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cortellini, A. | Bersanelli, M. | Pinato, D. | +1

CommentOn: Eur J Cancer. 2021 Jun;150:224-231. - PMID 33934059